US Stock MarketDetailed Quotes

ASLN Aslan Pharmaceuticals

Watchlist
  • 0.4410
  • -0.0190-4.13%
Trading May 1 11:59 ET
9.98MMarket Cap-160P/E (TTM)

Aslan Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aslan Pharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.75

+25.00%
Analyst Rating

Buy

Apr 30, 2024

Aslan Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: TWD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q2381.444M / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q2381.444M / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Aslan Pharmaceuticals Earnings Reports

  • Aslan Pharmaceuticals | 20-F: Registration statement / Annual report / Transition report

    Apr 12 18:31

  • Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 12 18:07

  • Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 13 19:28

  • Aslan Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 9, 2023 05:42

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg